Boardroom Alpha
Boardroom Alpha
AGNT · Additional Proxy Materials (DEFA14A) · Filed April 23, 2026

Exp World Holdings Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 23, 2026
Ticker
AGNT
Accession
0001104659-26-046936
Boardroom Alpha · Filing insights

eXp pushes Texas redomestication and defends a 3% derivative threshold preserving board accountability.

About Exp World Holdings Inc
Market cap
$790M
1Y TSR
−38.8%
3Y TSR
−32.7%
Board grade
C-
Sector
Real Estate
CEO
Glenn Darrel Sanford
Last annual meeting: Apr 24, 2026 · View full Exp World Holdings Inc profile →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. __ )

Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to §240.14a-12

eXp World Holdings, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

No fee required.

Fee paid previously with preliminary materials.

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.


eXp World Holdings, Inc. (“eXp” or the “Company”) filed its definitive proxy statement (the “Proxy Statement”) with the Securities and Exchange Commission (the “SEC”) on March 9, 2026 in connection with the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) to be held on Friday, April 24, 2026, at 12:00 p.m. Eastern Time. The following contains various communications related to the Proxy Statement and Annual Meeting, including investor communications related to the solicitation efforts in connection with the Company’s management proposal to redomesticate from Delaware to Texas (the “Texas Redomestication”).

Starting on April 22, 2026, eXp provided the below in communications to investors.

In the Company’s view, opting into the 3% derivative standing threshold does not eliminate meaningful avenues for board accountability. Shareholders with legitimate, well-founded claims can aggregate their holdings to meet the threshold. The provision is targeting nuisance or opportunistic litigation rather than insulating directors or management from meritorious claims.

Important Additional Information Regarding Proxy Solicitation

The Proxy Statement contains important information about the matters to be voted on at the 2026 Annual Meeting of Stockholders. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ALL RELEVANT DOCUMENTS FILED WITH OR FURNISHED TO THE SEC, BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT EXP AND THE MATTERS TO BE VOTED ON AT THE 2026 ANNUAL MEETING OF STOCKHOLDERS. Investors and stockholders will be able to obtain a copy of the Proxy Statement and other relevant documents filed by eXp free of charge from the SEC’s website, www.sec.gov. eXp’s stockholders will also be able to obtain, without charge, a copy of the Definitive Proxy Statement and other relevant filed documents by directing a request by mail to eXp World Holdings, Inc. Investor Relations, 2219 Rimland Dr., Suite 301, Bellingham, WA 98226 or at investors@expworldholdings.com.

Forward-Looking Statements

Statements related to the benefits and effects of the Texas Redomestication and other statements of future events or conditions following the Texas Redomestication are forward-looking statements. Actual future results or events, including, without limitation, future litigation, expectations related to the Texas business environment and Texas courts, potential benefits, implications, risks, costs, tax effects, costs savings or other related implications associated with the Texas Redomestication, the Company’s future financial position, growth opportunities and trends in the markets in which the Company operations, and prospects, plans and objectives of management and the Board, could differ materially due to a number of factors. These factors include, without limitation, legislative, regulatory, or judicial developments; unexpected costs, fees and expenses related to the Texas Redomestication; the nature, cost and outcome of any litigation and other legal proceedings, including any such proceedings related to the Texas Redomestication; unanticipated responses to the Texas Redomestication from customers, suppliers, other stakeholders and others with whom the Company does business; any inability to consummate the Texas Redomestication within the anticipated time period, or at all, due to any reason, including the failure to obtain the necessary stockholder or regulatory approvals; and other risks identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 24, 2026, the Proxy Statement filed with the SEC on March 9, 2026, and as otherwise described or updated from time to time in eXp’s other filings with the SEC.


From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Exp World Holdings Inc (AGNT)

Reference

Frequently asked questions

When did Exp World Holdings Inc file this DEFA14A?
Exp World Holdings Inc (AGNT) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 23, 2026. The accession number assigned by EDGAR is 0001104659-26-046936.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
eXp pushes Texas redomestication and defends a 3% derivative threshold preserving board accountability. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Exp World Holdings Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Exp World Holdings Inc has filed under CIK 1495932, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer